- Q32 bounces back to claim study success for alopecia drug<figure><div><img src="https://imgproxy.divecdn.com/_dT9zKJsCoS0jrFraV8Vdkcut5aCVtKPN0y1PuLlKnE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTUwMzE2NTA1LmpwZ…BioPharma Dive · 11d ago↗ source
- Agenus surges on study pivot; Apnimed lines up an IPO<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…BioPharma Dive · 11d ago↗ source
- STAT+: UnitedHealth’s questionable review, and more MA stars lawsuitsUnitedHealth touts a new home care audit, and more health insurers sue CMS over Medicare Advantage quality ratings.